Abstract:Chronic obstructive pulmonary disease (COPD) is a serious chronic lung disease. Schisandrin A (SchA) is one of the most important active ingredients in Schisandra chinensis and has been used to treat various lung diseases in several countries. Here, we studied the pharmacological effect of SchA on airway inflammation induced by cigarette smoke (CS) and explored the therapeutic mechanism of SchA in COPD model mice. Our results showed that SchA treatment significantly improved the lung function of CS-induced COPD model mice and reduced the recruitment of leukocytes and hypersecretion of interleukin-6 (IL-6), interleukin-1β (IL-1β) and tumor necrosis factor α (TNF-α) in bronchoalveolar lavage fluid (BALF). H&E staining showed that SchA treatment could effectively reduce emphysema, immune cell infiltration and airway wall destruction. In addition, we found that SchA treatment can stimulate the expression of heme oxygenase-1 (HO-1) through the nuclear factor-erythroid 2-related factor (Nrf2) pathway, significantly reduce oxidative stress, increase catalase (CAT) and superoxide dismutase (SOD) levels, and suppress the level of malondialdehyde (MDA) in COPD model mice. Moreover, SchA treatment suppressed the generation of the NLRP3/ASC/Caspase1 inflammasome complex to inhibit the inflammatory response caused by IL-1β and IL-18 and pyroptosis caused by GSDMD. In conclusion, our study shows that SchA treatment can inhibit the production of ROS and the activation of the NLRP3 inflammasome by upregulating Nrf-2, thereby producing anti-inflammatory effects and reducing lung injury in COPD model mice. More importantly, SchA exhibited similar anti-inflammatory effects to dexamethasone in COPD model mice, and we did not observe substantial side effects of SchA treatment. The high safety of SchA makes it a potential candidate drug for the treatment of COPD.

Schisandra A Ameliorates Cigarette Smoke Extract and Lipopolysaccharide-Induced Oxidative Stress in Lung Epithelial Cells

Schisandrin A regulates the Nrf2 signaling pathway and inhibits NLRP3 inflammasome activation to interfere with pyroptosis in a mouse model of COPD

Protective Effects of Schisandrin B on Cigarette Smoke-Induced Airway Injury in Mice Through Nrf2 Pathway.

Schisandrin Attenuates Lipopolysaccharide-Induced Lung Injury by Regulating TLR-4 and Akt/FoxO1 Signaling Pathways.

Effects of Schisandra chinensis extracts on cough and pulmonary inflammation in a cough hypersensitivity guinea pig model induced by cigarette smoke exposure

Therapeutic potential and mechanism of Dendrobium officinale polysaccharides on cigarette smoke-induced airway inflammation in rat

Protective Effects of Liquiritin Apioside on Cigarette Smoke‐induced Lung Epithelial Cell Injury

Luteolin Alleviates Oxidative Stress in Chronic Obstructive Pulmonary Disease Induced by Cigarette Smoke via Modulation of the TRPV1 and CYP2A13/NRF2 Signaling Pathways

Schisandrin B Attenuates Lipopolysaccharide-Induced Activation Of Hepatic Stellate Cells Through Nrf-2-Activating Anti-Oxidative Activity

(−)-Epicatechin Ameliorates Cigarette Smoke-Induced Lung Inflammation Via Inhibiting ROS/NLRP3 Inflammasome Pathway in Rats with COPD

Sodium Tanshinone IIA Sulfonate Protects Against Acute Exacerbation of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease in Mice.

Tanshinone IIA Sulfonate Protects Against Cigarette Smoke-Induced COPD and Down-Regulation of CFTR in Mice

Cryptotanshinone alleviates lipopolysaccharide and cigarette smoke-induced chronic obstructive pulmonary disease in mice via the Keap1/Nrf2 axis

Anti-pneumoconiosis effect of schisantherin A in PMA-induced A549 cells and SiO2/TiO2nanoparticles-induced acute pulmonary injury in mice

Trans-4,4'-dihydroxystilbene ameliorates cigarette smoke-induced progression of chronic obstructive pulmonary disease via inhibiting oxidative stress and inflammatory response

Inhibitory effects of Schisandrin C on collagen behavior in pulmonary fibrosis

Schisandrin C Targets Keap1 and Attenuates Oxidative Stress by Activating Nrf2 Pathway in Ang II‐challenged Vascular Endothelium

Schisandrol A Alleviates Allergic Asthma in Mice via Regulating the NF-κB/IκBα and Nrf2/HO-1 Signaling Pathways

Pharmacological Investigation Of The Anti-Inflammation And Anti-Oxidation Activities Of Diallyl Disulfide In A Rat Emphysema Model Induced By Cigarette Smoke Extract

Schisandrin B protects against angiotensin II-induced endotheliocyte deficits by targeting Keap1 and activating Nrf2 pathway.

Cryptotanshinone Attenuates Airway Inflammation Induced by Cigarette Smoke in Mice